Field & Main Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.17K | Hold |
35
| – | – | ﹤0.01% | 259 |
|
|
2026
Q1 | $2.8K | Hold |
35
| – | – | ﹤0.01% | 249 |
|
|
2025
Q4 | $2.98K | Hold |
35
| – | – | ﹤0.01% | 248 |
|
|
2025
Q3 | $2.72K | Hold |
35
| – | – | ﹤0.01% | 243 |
|
|
2025
Q2 | $2.74K | Hold |
35
| – | – | ﹤0.01% | 232 |
|
|
2025
Q1 | $2.54K | Sell |
35
-65
| -65% | -$4.65K | ﹤0.01% | 233 |
|
|
2024
Q4 | $7.4K | Hold |
100
| – | – | ﹤0.01% | 239 |
|
|
2024
Q3 | $6.6K | Hold |
100
| – | – | ﹤0.01% | 227 |
|
|
2024
Q2 | $9.24K | Hold |
100
| – | – | ﹤0.01% | 229 |
|
|
2024
Q1 | $9.55K | Hold |
100
| – | – | ﹤0.01% | 226 |
|
|
2023
Q4 | $7.62K | Hold |
100
| – | – | ﹤0.01% | 228 |
|
|
2023
Q3 | $6.93K | Sell |
100
-389
| -80% | -$31.3K | ﹤0.01% | 231 |
|
|
2023
Q2 | $46.1K | Hold |
489
| – | – | 0.03% | 179 |
|
|
2023
Q1 | $40.5K | Sell |
489
-75
| -13% | -$5.89K | 0.02% | 176 |
|
|
2022
Q4 | $42.1K | Hold |
564
| – | – | 0.03% | 174 |
|
|
2022
Q3 | $47K | Sell |
564
-103
| -15% | -$9.91K | 0.03% | 170 |
|
|
2022
Q2 | $63K | Buy |
667
+317
| +91% | +$32.8K | 0.04% | 162 |
|
|
2022
Q1 | $41K | Hold |
350
| – | – | 0.02% | 167 |
|
|
2021
Q4 | $45K | Sell |
350
-125
| -26% | -$14.6K | 0.03% | 167 |
|
|
2021
Q3 | $54K | Buy |
475
+100
| +27% | +$11.4K | 0.04% | 155 |
|
|
2021
Q2 | $39K | Hold |
375
| – | – | 0.03% | 158 |
|
|
2021
Q1 | $31K | Hold |
375
| – | – | 0.02% | 154 |
|
|
2020
Q4 | $34K | Sell |
375
-6
| -2% | -$498 | 0.03% | 147 |
|
|
2020
Q3 | $30K | Hold |
381
| – | – | 0.02% | 151 |
|
|
2020
Q2 | $26K | Buy |
+381
| New | +$27.1K | 0.02% | 148 |
|
|
2019
Q4 | $41K | Hold |
531
| – | – | 0.03% | 151 |
|
|
2019
Q3 | $39K | Hold |
531
| – | – | 0.04% | 152 |
|
|
2019
Q2 | $33K | Hold |
531
| – | – | 0.03% | 161 |
|
|
2019
Q1 | $34K | Buy |
+531
| New | +$30.3K | 0.03% | 154 |
|
|
2018
Q3 | $37K | Sell |
630
-84
| -12% | -$4.11K | 0.03% | 167 |
|
|
2018
Q2 | $34K | Buy |
714
+165
| +30% | +$7.7K | 0.03% | 169 |
|
|
2018
Q1 | $26K | Hold |
549
| – | – | 0.03% | 177 |
|
|
2017
Q4 | $21K | Buy |
+549
| New | +$20.1K | 0.02% | 184 |
|
Other funds holding EW
Field & Main Bank's EW Position: Q2 2026 in Review
Field & Main Bank held its Edwards Lifesciences (EW) position steady in Q2 2026 at 35 shares worth $3.17K. The position accounts for ﹤0.01% of the portfolio, ranked #259.
Field & Main Bank first reported a position in EW in Q4 2017 and has held it in 33 quarters since. The position peaked at $63K in Q2 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Field & Main Bank held 35 shares of Edwards Lifesciences worth $3.17K as of Q2 2026.
- Field & Main Bank left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up ﹤0.01% of Field & Main Bank's portfolio in Q2 2026, its #259 holding.
- Field & Main Bank first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 33 quarters since.
- Field & Main Bank's Edwards Lifesciences position peaked at $63K in Q2 2022.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Field & Main Bank's 13F filing for Q2 2026, filed 13 Aug 2026.